Cerebras Systems gave back a chunk of its blockbuster debut on its second day as a public company. Shares of the AI chipmaker fell roughly 10% on the Nasdaq, settling near $280 after closing their first session at $311.07. The pullback trimmed the gains from a 68% first-day surge but still left the stock about 51% above its $185 offering price, a gap wide enough to reward IPO-allocation holders and sting anyone who bought near the top of the Day 1 frenzy.
How the IPO came together
Cerebras sold 6,760,000 shares to the public at $185 apiece, raising $1,250,600,000 in gross proceeds before underwriting discounts, according to the 424(b)(4) prospectus filed with the SEC. The deal was led by Citigroup and Barclays, with additional underwriting from Jefferies, Mizuho, and others listed in the filing. An overallotment option could push total proceeds higher if underwriters exercise it in full.
At the offering price, Cerebras carried a fully diluted valuation of roughly $5.5 billion, derived from the approximately 29.7 million fully diluted shares disclosed in the prospectus multiplied by the $185 price. That made it one of the largest venture-backed AI hardware companies to reach the public markets, though the deal’s size was well below the $4.87 billion Arm Holdings raised in its September 2023 IPO. The first-day close of $311.07 pushed Cerebras’s implied market capitalization above $9 billion, a figure that prices in enormous expectations for a company still operating at a loss.
What Cerebras actually builds
The company, founded in 2016 by CEO Andrew Feldman and a team of chip architects, is built around a contrarian bet: instead of networking thousands of small GPUs into massive clusters, build one processor the size of an entire silicon wafer. The result is the Wafer-Scale Engine 3 (WSE-3), which packs roughly 4 trillion transistors onto a single piece of silicon, according to Cerebras’s own product specifications. The WSE-3 powers the company’s CS-3 system and a software stack designed to train and run large AI models.
That architecture puts Cerebras in direct competition with Nvidia, whose H100 and Blackwell-generation B200 GPUs dominate AI training infrastructure, as well as AMD’s Instinct MI series and the custom silicon programs run by hyperscalers like Google (TPUs) and Amazon (Trainium). Cerebras argues its approach delivers better performance per dollar for certain large-scale workloads, but the company’s amended registration statement is candid about the competitive gap in market share and customer reach.
Revenue, losses, and the G42 question
The S-1/A filing gives investors a clearer picture of where Cerebras stands financially, and it is not yet a profitable business. Revenue has grown rapidly, driven by shipments of its wafer-scale systems, but the company has posted significant net losses as it invests heavily in R&D, manufacturing partnerships, and go-to-market operations. Gross margins, while improving, remain under pressure from the cost of producing chips at wafer scale through its fabrication partner, TSMC.
Perhaps the most scrutinized detail in the filings is customer concentration. A substantial portion of Cerebras’s recent revenue has come from contracts linked to G42, the Abu Dhabi-based AI firm. That relationship drew regulatory attention before the IPO, and the filing acknowledges that dependence on a small number of large buyers means the loss or delay of even one major contract could materially affect results. Diversifying that customer base is one of the central challenges Cerebras faces as a public company.
Why the stock pulled back on Day 2
No block-trade disclosures or company statements have surfaced to explain the decline, but the simplest explanation is profit-taking. Institutional investors who received allocations at $185 were sitting on a 68% paper gain by the first-day close. Locking in that kind of return within hours is routine after a hot debut and does not require any change in long-term conviction to trigger selling.
Broader market conditions may have contributed as well, though separating macro effects from IPO-specific dynamics is difficult without more granular trading data. The Day 2 closing price has not been confirmed by an independent source beyond the approximate $280 level observed in market data. What matters is that the pullback, while sharp in percentage terms, did not erase the bulk of the first-day gains. A stock that prices at $185, closes Day 1 near $311, and trades around $280 on Day 2 is still reflecting strong demand, not a failed offering.
The risks laid out in the filings
Beyond customer concentration, the prospectus flags several risks that tend to get overlooked in the excitement of a big debut. Use of proceeds is directed toward manufacturing expansion and research, both capital-intensive and carrying real execution risk. Cerebras is still in an aggressive investment phase, with large planned outlays for fabrication capacity, advanced packaging, and software ecosystem development. Converting those investments into sustainable free cash flow as a public company remains unproven.
Lock-up agreements restrict insiders and early investors from selling shares for a set period after the IPO. When those restrictions expire, a new wave of supply could hit the market. The specific terms are disclosed in the prospectus, but the actual impact depends on how many holders choose to sell and at what price.
What Cerebras must prove before the lock-up expires
Investors are now waiting for Cerebras to deliver its first quarterly earnings as a public company. The IPO filings provide a snapshot, but the real test is whether the company can grow revenue, broaden its customer base beyond a concentrated few, and narrow its losses on a timeline that justifies a $9 billion-plus implied valuation.
Competitive response adds another layer of uncertainty. Nvidia has a long track record of aggressive product cycles and pricing adjustments when challengers gain traction. AMD continues to invest in its Instinct lineup for AI workloads. And the hyperscalers’ internal chip programs reduce their dependence on any outside supplier, Cerebras included. How those incumbents react to a newly public rival sitting on more than a billion dollars in fresh capital could reshape the growth assumptions currently baked into the stock.
For investors who got in at $185, the position remains deeply profitable. For those who bought near the Day 1 highs, the Day 2 drop is a reminder that IPO volatility works in both directions. And for the broader market, Cerebras has established itself as the most prominent pure-play AI chip company trading on a U.S. exchange. That status guarantees attention. Whether it guarantees returns depends entirely on what the company reports in the quarters ahead.
